" 26.31 
purpose. 
(a) the purpose of this subpart is to specify the conditions under which a party will accept the results of quality system-related evaluations and inspections and premarket evaluations of the other party with regard to medical devices as conducted by listed conformity assessment bodies (cab's) and to provide for other related cooperative activities. 
(b) this subpart is intended to evolve as programs and policies of the parties evolve. the parties will review this subpart periodically, in order to assess progress and identify potential enhancements to this subpart as food and drug administration (fda) and european community (ec) policies evolve over time.", 
